Skewed megakaryopoiesis in human induced pluripotent stem cell-derived haematopoietic progenitor cells harbouring calreticulin mutations
Skewed megakaryopoiesis in human induced pluripotent stem cell-derived haematopoietic progenitor cells harbouring calreticulin mutations
复制标题
含有钙网蛋白突变的人诱导多能干细胞衍生的造血祖细胞的巨核细胞生成发生偏差
DOI:
10.1111/bjh.15266
复制
发表时间:
2018
影响因子:
6.5
通讯作者:
Norio Komatsu
中科院分区:
文献类型:
--
作者:
Hiraku Takei;Yoko Edahiro;Shuichi Mano;Nami Masubuchi;Yoshihsa Mizukami;Misa Imai;Soji Morishita;Kyohei Misawa;Tomonori Ochiai;Satoshi Tsuneda;Hiroshi Endo;Sou Nakamura;Koji Eto;Akimichi Ohsaka;Marito Araki;Norio Komatsu
Somatic mutations in thecalreticulin(CALR) gene have been found in most patients withJAK2‐ andMPL‐unmutated Philadelphia chromosome‐negative myeloproliferative neoplasms (MPNs). It has recently been shown that mutant CALR constitutively activates the thrombopoietin receptor MPL and, thus, plays a causal role in the development of MPNs. However, the roles of mutant CALR in human haematopoietic cell differentiation remain predominantly elusive. To examine the impact of the 5‐base insertion mutantCALRgene (Ins5) on haematopoietic cell differentiation, we generated induced pluripotent stem cells from an essential thrombocythaemia (ET) patient harbouring aCALR‐Ins5 mutation and from a healthy individual (WT). Megakaryopoiesis was more prominent in Ins5‐haematopoietic progenitor cells (Ins5‐HPCs) than in WT‐HPCs, implying that the system recapitulates megakaryocytosis observed in the bone marrow ofCALR‐mutant ET patients. Ins5‐HPCs exhibited elevated expression levels ofGATA1andGATA2,suggesting a premature commitment to megakaryocytic differentiation in progenitor cells. We also demonstrated that 3‐hydroxy anagrelide markedly perturbed megakaryopoiesis, but not erythropoiesis. Collectively, we established anin vitromodel system that recapitulates megakaryopoiesis caused by mutantCALR. This system can be used to validate therapeutic compounds for MPN patients harbouringCALRmutations and in detailed studies on mutant CALR in human haematological cell differentiation.